Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cavitation Technologies (CVAT) Operating Expenses (2016 - 2025)

Cavitation Technologies (CVAT) has disclosed Operating Expenses for 16 consecutive years, with $474000.0 as the latest value for Q4 2025.

  • Quarterly Operating Expenses rose 30.94% to $474000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.3 million through Dec 2025, up 37.97% year-over-year, with the annual reading at $1.2 million for FY2025, 49.8% up from the prior year.
  • Operating Expenses hit $474000.0 in Q4 2025 for Cavitation Technologies, up from $252000.0 in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $785000.0 in Q2 2022 to a low of $168000.0 in Q2 2024.
  • Historically, Operating Expenses has averaged $322350.0 across 5 years, with a median of $284500.0 in 2021.
  • Biggest five-year swings in Operating Expenses: crashed 58.47% in 2023 and later surged 110.47% in 2024.
  • Year by year, Operating Expenses stood at $548000.0 in 2021, then tumbled by 39.42% to $332000.0 in 2022, then plummeted by 48.19% to $172000.0 in 2023, then soared by 110.47% to $362000.0 in 2024, then skyrocketed by 30.94% to $474000.0 in 2025.
  • Business Quant data shows Operating Expenses for CVAT at $474000.0 in Q4 2025, $252000.0 in Q3 2025, and $239000.0 in Q2 2025.